Skip to content

Study · Other design · 1986

2 results

Solid phase synthesis of thymosin beta 9.

Chandramouli N, Bhargava KK, Incefy GS, Modak MJ, Merrifield RB

International journal of peptide and protein research1 Nov 1986Cited by 1 (Europe PMC)

PMID3818171 (opens in a new tab)DOI10.1111/j.1399-3011.1986.tb03289.x (opens in a new tab)PepBankPUB-03818171
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabOther designActivity measurement

    In the rosette inhibition assay, thymosin alpha‑1 was active.

    In plain wordsIn lab tests, thymosin alpha‑1 was active in the rosette inhibition assay.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableActivity in the rosette inhibition assay
    Study

    n: not reported in source

    Rosette inhibition assay
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In contrast to thymosin alpha 1, neither beta 4 nor beta 9 was active in the rosette inhibition assay.
  2. 02LabOther designActivity measurement

    In the rosette inhibition assay, thymosin beta‑4 was not active, in contrast to thymosin alpha 1.

    In plain wordsIn lab tests, thymosin beta‑4 was not active in the rosette inhibition assay, unlike thymosin alpha 1.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    No significant changeActivity in the rosette inhibition assay
    Study

    n: not reported in source

    Rosette inhibition assay
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In contrast to thymosin alpha 1, neither beta 4 nor beta 9 was active in the rosette inhibition assay.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    12 Oct 2026, 18:17 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    10 Oct 2026, 08:55 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.